Please use this identifier to cite or link to this item:
http://hdl.handle.net/10773/31159
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Carneiro, Tatiana J. | pt_PT |
dc.contributor.author | Martins, Ana S. | pt_PT |
dc.contributor.author | Marques, M. Paula M. | pt_PT |
dc.contributor.author | Gil, Ana M. | pt_PT |
dc.date.accessioned | 2021-04-12T16:48:55Z | - |
dc.date.available | 2021-04-12T16:48:55Z | - |
dc.date.issued | 2020-10-12 | - |
dc.identifier.issn | 2234943X | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10773/31159 | - |
dc.description.abstract | This mini-review reports on the existing knowledge of the metabolic effects of palladium [Pd(II)] complexes with potential anticancer activity, on cell lines and murine models. Most studies have addressed mononuclear Pd(II) complexes, although increasing interest has been noted in bidentate complexes, as polynuclear structures. In addition, the majority of records have reported in vitro studies on cancer cell lines, some including the impact on healthy cells, as potentially informative in relation to side effects. Generally, these studies address metabolic effects related to the mechanisms of induced cell death and antioxidant defense, often involving the measurement of gene and protein expression patterns, and evaluation of the levels of reactive oxygen species or specific metabolites, such as ATP and glutathione, in relation to mitochondrial respiration and antioxidant mechanisms. An important tendency is noted toward the use of more untargeted approaches, such as the use of omic sciences e.g., proteomics and metabolomics. In the discussion section of this mini-review, the developments carried out so far are summarized and suggestions of possible future developments are advanced, aiming at recognizing that metabolites and metabolic pathways make up an important part of cell response and adaptation to therapeutic agents, their further study potentially contributing valuably for a more complete understanding of processes such as biotoxicity or development of drug resistance. | pt_PT |
dc.description.sponsorship | AG acknowledges funding from the CICECO-Aveiro Institute of Materials project, with references UIDB/50011/2020 & UIDP/50011/2020, financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. MM acknowledges financial support from POCentro, COMPETE 2020, Portugal 2020 and European Community through the FEDER and the Portuguese Foundation for Science and Technology (UIDB/00070/2020). TC and AM are grateful to the Portuguese Foundation for Science and Technology (FCT) for grants SFRH/BD/145920/2019 and SFRH/BD/111576/2015, respectively. | pt_PT |
dc.language.iso | eng | pt_PT |
dc.publisher | Frontiers Media S.A. | pt_PT |
dc.relation | SFRH/BD/111576/2015 | pt_PT |
dc.relation | SFRH/BD/145920/2019 | pt_PT |
dc.relation | UIDB/00070/2020 | pt_PT |
dc.relation | UIDB/50011/2020 | pt_PT |
dc.relation | UIDP/ 50011/2020 | pt_PT |
dc.rights | openAccess | pt_PT |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Palladium | pt_PT |
dc.subject | Complexes | pt_PT |
dc.subject | Chelates | pt_PT |
dc.subject | Anti-cancer activity | pt_PT |
dc.subject | Metabolism | pt_PT |
dc.title | Metabolic aspects of palladium(II) potential anti-cancer drugs | pt_PT |
dc.type | article | pt_PT |
dc.description.version | published | pt_PT |
dc.peerreviewed | yes | pt_PT |
degois.publication.firstPage | 1 | pt_PT |
degois.publication.lastPage | 8 | pt_PT |
degois.publication.title | Frontiers in Oncology | pt_PT |
degois.publication.volume | 10 | pt_PT |
dc.identifier.doi | 10.3389/fonc.2020.590970 | pt_PT |
dc.identifier.essn | 2234943X | pt_PT |
Appears in Collections: | CICECO - Artigos DQ - Artigos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2020CarneiroTJ_Pd(II)-drugs_Metabolic_aspects_MiniReview.pdf | 765.62 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.